Differential diagnosis and management of acute profound thrombocytopenia by tirofiban: A case report

    loading  Checking for direct PDF access through Ovid

Abstract

Summary

Although the glycoprotein IIb/IIIa receptor inhibitors have improved outcomes of patients with acute coronary syndrome (ACS), therapy with these agents may cause thrombocytopenia with bleeding complications. This adverse effect is seemed to be rare with tirofiban. In this report, we describe a case of acute profound thrombocytopenia within two hours of tirofiban administration and review the differential diagnosis and the management of thrombocytopenia.

Related Topics

    loading  Loading Related Articles